# OLANZAPINE

NDC: 55150-308
Generic name: OLANZAPINE
Labeler / Manufacturer: Eugia US LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAMUSCULAR
Marketing started: 20201022

FDA application: ANDA210968

## Active ingredients

- OLANZAPINE: 10 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"55150-308"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=55150-308
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9c745e2e-89d3-44d4-906e-704705c33310